Three-Zone Biosecurity Offers New Hope to Indonesian Farmers
James McGrane, FAO ECTAD Indonesia Team Leader, at his office in Jakarta. Credit: Kanis Dursin/IPSBy Kanis DursinJAKARTA, Indonesia, Jul 10 2017 (IPS)Poultry farmer Bambang Sutrisno Setiawan had long heard about biosecurity but never gave serious thought to it, even when the highly pathogenic avian influenza H5N1 forced him to cull thousands of his layer chickens in 2003 and 2009.Eighteen years into the business, however, Bambang, who is called Ilung by friends, is now converting his second farm into a three-zone biosecurity poultry with a strong conviction that it is the only way to save his business amid continued threats of bird flu and other animal diseases.Indonesia detected its first bird flu case in 2003. Since then, the H5N1 virus has killed millions of poultry in 32 of the country’s 34 provinces.“My second poultry biosecurity will soon operate, hopefully in July,” Ilung told IPS by phone from Semarang, Central Java, a one-hour flight east of the capital Jakarta, in mid-June.The 44-year-old has two poultry farms, each accommodating around 30,000 layers, and one day-old chick site that can hold 10,000 chicks.Ilung converted one of his farms into biosecurity poultry in November 2015 after attending seminars and trainings organized by local Livestock and Animal Health Services and Food and Agriculture Organization’s Emergency Center for Transboundary Animal Diseases (ECTAD).Three-zone biosecurity is one of programs ECTAD Indonesia is promoting to ...
Weizhe Zhang, Guangxu Ren, Wei Zhao, Ziyin Yang, Yujuan Shen, Yihua Sun, Aiqin Liu, Jianping Cao
Point of care (POC) testing has emerged as a critical tool in the early and rapid diagnosis and treatment of infectious diseases. While the mainstay of these POC tests has been lateral-flow-based antigen detection assays, recent technological advances in nucleic acid detection combined with regulatory changes has allowed more sensitive detection of infectious etiologies in the near-patient setting. This advancement is particularly impactful in the ambulatory setting, where rapid diagnosis can ensure appropriate treatment at the early stages of infection, both preventing more serious sequelae and also improving physician wo...
Background: Lung transplant recipients have an increased risk for infections in the posttransplant period due to immunosuppressive therapy. Protection against infections can be achieved through vaccination, but the optimal vaccination schedule in lung transplant recipients is unknown. Data on long-term immunological follow up and vaccination responses after lung transplantation are scarce. Methods: Here we present long-term immunological follow up of a cohort of 55 lung transplant recipients. This includes detailed antibody responses after 23-valent pneumococcal polysaccharide vaccination (23vPPV). Results: All patients ...
Authors: Okada Y, Okada A, Narumiya H, Iiduka R, Katsura K Abstract A previously healthy 55-year-old man with H1N1 influenza A presented with severe respiratory failure and cardiac arrest. Following the return of spontaneous circulation, venovenous extracorporeal membrane oxygenation was required to maintain oxygenation. On day 2, bronchoscopy revealed a bloody bronchial cast obstructing the right main bronchus. A pathological examination revealed that it was composed of intrabronchial and intra-alveolar hemorrhagic tissue. Unfortunately, the patient died due to severe brain ischemia; a subsequent autopsy revealed ...
27 –28 September 2017, London, United Kingdom
[Premium Times] The Federal Government is tracking four major diseases out breaks in Nigeria, Health Minister, Isaac Adewole, has disclosed.
On Sept 1, the pharmaceutical company Sanofi Pasteur announced that it was withdrawing from development of a vaccine against Zika virus infection. This announcement raises concerns about the future of Zika virus vaccine development, at a time when the number of cases is falling and other questions about the virus remain unanswered.
Zika virus, similar to dengue, yellow fever, and chikungunya viruses, predominantly exists in a transmission cycle between human beings and anthropophilic mosquitoes.1 Because of its intrinsic ability to transmit the virus and affiliation with human beings, the primary mosquito vector of Zika virus during outbreaks is Aedes aegypti.2 In early 2016, researchers in northeastern Brazil announced that another mosquito species, Culex quinquefasciatus, which also inhabits domestic environments, could be involved in the transmission of Zika virus.
Hand, foot, and mouth disease (HFMD) is a common infectious disease caused by a group of enteroviruses, including coxsackievirus A16 (CA16) and enterovirus 71 (EV71).1 Mainland China experienced several large outbreaks of HFMD in 2007 and early 2008 and established a national enhanced surveillance system partly in response to these outbreaks.2 On May 2, 2008, HFMD was listed as a category C infectious disease and made statutorily notifiable.3
In their Article in The Lancet Infectious Diseases, Matthew Waxman and colleagues1 report an overall high (8 ·1%) mortality in patients without Ebola virus disease (EVD) admitted to three Ebola treatment units (ETU) in Sierra Leone; we report a similarly high (6·4%) mortality in non-EVD cases from a Guinean ETU.2 We agree with the authors that many non-EVD patients succumb to other severe illnesses, prob ably infectious diseases within a broad differential diagnosis given the high frequency of fever in the context of a negative malaria test.
More News: Anthrax | Anthrax Vaccine | Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Ebola | Ebola Vaccine | Economy | Egypt Health | Emergency Medicine | Endemics | Environmental Health | Epidemiology | Genetics | Government | H5N1 | Indonesia Health | Influenza | Influenza Vaccine | International Medicine & Public Health | MERS | Nutrition | Outbreaks | Rabies | Rural Health | Solo Practices | Study | Toxicology | United Nations | Vaccines | Veterinary Vaccinations | Vietnam Health | WHO | Zika Virus | Zoonoses